These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8023555)

  • 41. [Construction of recombinant vaccinia virus expressing HPV18E7E6 fusion proteins and detection of its immunogenicity in mice].
    Zhao L; Ren J; Feng J; Gao J; Zhang H; Tian HW; Ruan L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):189-91. PubMed ID: 19031699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved protection conferred by vaccination with a recombinant vaccinia virus that incorporates a foreign antigen into the extracellular enveloped virion.
    Kwak H; Mustafa W; Speirs K; Abdool AJ; Paterson Y; Isaacs SN
    Virology; 2004 May; 322(2):337-48. PubMed ID: 15110531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus.
    Forrester AJ; Sullivan V; Simmons A; Blacklaws BA; Smith GL; Nash AA; Minson AC
    J Gen Virol; 1991 Feb; 72 ( Pt 2)():369-75. PubMed ID: 1704412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance of Homologous and Heterologous Prime-Boost Immunization Regimens of Recombinant Adenovirus and Modified Vaccinia Virus Ankara Expressing an Ag85B-TB10.4 Fusion Protein against
    Kou Y; Wan M; Shi W; Liu J; Zhao Z; Xu Y; Wei W; Sun B; Gao F; Cai L; Jiang C
    J Microbiol Biotechnol; 2018 Jun; 28(6):1022-1029. PubMed ID: 29847865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of envelope glycoprotein (E) of Japanese encephalitis virus by recombinant vaccinia virus.
    Haishi S; Imai H; Hirai K; Igarashi A; Kato S
    Acta Virol; 1989 Dec; 33(6):497-503. PubMed ID: 2576591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bovine Anaplasmosis: Will there ever be an almighty effective vaccine?
    Salinas-Estrella E; Amaro-Estrada I; Cobaxin-Cárdenas ME; Preciado de la Torre JF; Rodríguez SD
    Front Vet Sci; 2022; 9():946545. PubMed ID: 36277070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antigens and alternatives for control of Anaplasma marginale infection in cattle.
    Kocan KM; de la Fuente J; Guglielmone AA; Meléndez RD
    Clin Microbiol Rev; 2003 Oct; 16(4):698-712. PubMed ID: 14557295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Major histocompatibility complex class II DR-restricted memory CD4(+) T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a.
    Brown WC; McGuire TC; Mwangi W; Kegerreis KA; Macmillan H; Lewin HA; Palmer GH
    Infect Immun; 2002 Oct; 70(10):5521-32. PubMed ID: 12228278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD4(+) T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strains.
    Brown WC; Palmer GH; Lewin HA; McGuire TC
    Infect Immun; 2001 Nov; 69(11):6853-62. PubMed ID: 11598059
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biased immunoglobulin G1 isotype responses induced in cattle with DNA expressing msp1a of Anaplasma marginale.
    Arulkanthan A; Brown WC; McGuire TC; Knowles DP
    Infect Immun; 1999 Jul; 67(7):3481-7. PubMed ID: 10377129
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of major surface protein 2 antigenic variants during acute Anaplasma marginale rickettsemia.
    Eid G; French DM; Lundgren AM; Barbet AF; McElwain TF; Palmer GH
    Infect Immun; 1996 Mar; 64(3):836-41. PubMed ID: 8641789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evolution and function of tandem repeats in the major surface protein 1a of the ehrlichial pathogen Anaplasma marginale.
    de La Fuente J; Garcia-Garcia JC; Blouin EF; Rodríguez SD; García MA; Kocan KM
    Anim Health Res Rev; 2001 Dec; 2(2):163-73. PubMed ID: 11831437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Probing the signal for glycophosphatidylinositol anchor attachment using decay accelerating factor as a model system.
    Caras IW
    Cell Biol Int Rep; 1991 Sep; 15(9):815-26. PubMed ID: 1724950
    [No Abstract]   [Full Text] [Related]  

  • 54. Recombinant vaccinia virus expression of Anaplasma marginale surface protein MSP-1a: effect of promoters, leader sequences and GPI anchor sequence on antibody response.
    McGuire TC; Stephens EB; Palmer GH; McElwain TF; Lichtensteiger CA; Leib SR; Barbet AF
    Vaccine; 1994 Apr; 12(5):465-71. PubMed ID: 8023555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mapping of B-cell epitopes in the N-terminal repeated peptides of Anaplasma marginale major surface protein 1a and characterization of the humoral immune response of cattle immunized with recombinant and whole organism antigens.
    Garcia-Garcia JC; de la Fuente J; Kocan KM; Blouin EF; Halbur T; Onet VC; Saliki JT
    Vet Immunol Immunopathol; 2004 Apr; 98(3-4):137-51. PubMed ID: 15010223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antigenic characterization of Brazilian isolates of Anaplasma marginale.
    Oliveira JB; Madruga CR; Schenk MA; Kessler RH; Miguita M; Araújo FR
    Mem Inst Oswaldo Cruz; 2003 Apr; 98(3):395-400. PubMed ID: 12886423
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.